Predictors of non-healing in patients with critical limb ischemia and tissue loss following successful endovascular therapy

Catheterization and Cardiovascular Interventions

Volumn 85, Issue 5, 2015, Pages 850-858

  Kobayashi, Norihiro ^a   Hirano, Keisuke ^a   Nakano, Masatsugu ^a   Muramatsu, Toshiya ^a   Tsukahara, Reiko ^a   Ito, Yoshiaki ^a   Ishimori, Hiroshi ^a   Yamawaki, Masahiro ^a   Araki, Motoharu ^a   Kato, Tamon ^a  

^a SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

Author keywords

critical limb ischemia; endovascular therapy; wound healing

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; INSULIN;

AGED; ARTICLE; BALLOON; CLINICAL EFFECTIVENESS; CRITICAL LIMB ISCHEMIA; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG USE; ENDOVASCULAR SURGERY; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; LEG REVASCULARIZATION; LIMB BLOOD FLOW; LIMB INJURY; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SELF EXPANDING STENT; SURGICAL WIRE; TISSUE BLOOD FLOW; TISSUE INJURY; TREATMENT INDICATION; WOUND CARE; WOUND HEALING IMPAIRMENT; ISCHEMIA; LEG; PROGNOSIS; RISK FACTOR; SURGICAL WOUND DEHISCENCE; TIME; VASCULARIZATION; WOUND HEALING;

AGED; ENDOVASCULAR PROCEDURES; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISCHEMIA; LOWER EXTREMITY; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL WOUND DEHISCENCE; TIME FACTORS; WOUND HEALING;

EID: 84925301809     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25625     Document Type: Article

References (37)

1. Soderstrom MI, Arvela EM, Korhonen M, Halmesmaki KH, Alback AN, Biancari F, Lepantalo MJ, Venermo MA,. Infrapopliteal percutaneous transluminal angioplasty versus bypass surgery as first-line strategies in critical leg ischemia: A propensity score analysis. Ann Surg 2010; 252: 765-773.
2. Soga Y, Mii S, Aihara H, Okazaki J, Kuma S, Yamaoka T, Kamoi D, Shintani Y, Ishikawa T, Re CI,. Comparison of clinical outcome after bypass surgery vs. endovascular therapy for infrainguinal artery disease in patients with critical limb ischemia. Circ J 2013; 77: 2102-2109.
3. Dietzek AM, Gupta SK, Kram HB, Wengerter KR, Veith FJ,. Limb loss with patent infra-inguinal bypasses. Eur J Vasc Surg 1990; 4: 413-417.
4. Simons JP, Goodney PP, Nolan BW, Cronenwett JL, Messina LM, Schanzer A,. Failure to achieve clinical improvement despite graft patency in patients undergoing infrainguinal lower extremity bypass for critical limb ischemia. J Vasc Surg 2010; 51: 1419-1424.
5. Carsten CG III, Taylor SM, Langan EM III, Crane MM,. Factors associated with limb loss despite a patent infrainguinal bypass graft. Am Surg 1998; 64: 33-37; discussion 37-38.
6. Khan MU, Lall P, Harris LM, Dryjski ML, Dosluoglu HH,. Predictors of limb loss despite a patent endovascular-treated arterial segment. J Vasc Surg 2009; 49: 1440-1445; discussion 1445-1446.
7. Iida O, Nanto S, Uematsu M, Ikeoka K, Okamoto S, Dohi T, Fujita M, Terashi H, Nagata S,. Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia. Catheter Cardiovasc Interv 2010; 75: 830-836.
8. Kabra A, Suresh KR, Vivekanand V, Vishnu M, Sumanth R, Nekkanti M,. Outcomes of angiosome and non-angiosome targeted revascularization in critical lower limb ischemia. J Vasc Surg 2013; 57: 44-49.
9. Feiring AJ, Krahn M, Nelson L, Wesolowski A, Eastwood D, Szabo A,. Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: The PaRADISE (PReventing Amputations using Drug eluting StEnts) trial. J Am Coll Cardiol 2010; 55: 1580-1589.
10. Azuma N, Uchida H, Kokubo T, Koya A, Akasaka N, Sasajima T,. Factors influencing wound healing of critical ischaemic foot after bypass surgery: Is the angiosome important in selecting bypass target artery? Eur J Vasc Endovasc Surg 2012; 43: 322-328.
11. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Eur J Vasc Endovasc Surg 2000; 19 (Suppl A): Si-xxviii, S1-S250.
12. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN,. Recommended standards for reports dealing with lower extremity ischemia: Revised version. J Vasc Surg 1997; 26: 517-538.
13. Schultz GS, Barillo DJ, Mozingo DW, Chin GA, Wound Bed Advisory Board M,. Wound bed preparation and a brief history of TIME. Int Wound J 2004; 1: 19-32.
14. Kawarada O, Fujihara M, Higashimori A, Yokoi Y, Honda Y, Fitzgerald PJ,. Predictors of adverse clinical outcomes after successful infrapopliteal intervention. Catheter Cardiovasc Interv 2012; 80: 861-871.
15. Chung J, Bartelson BB, Hiatt WR, Peyton BD, McLafferty RB, Hopley CW, Salter KD, Nehler MR,. Wound healing and functional outcomes after infrainguinal bypass with reversed saphenous vein for critical limb ischemia. J Vasc Surg 2006; 43: 1183-1190.
16. Acin F, Varela C, Lopez de Maturana I, de Haro J, Bleda S, Rodriguez-Padilla J,. Results of infrapopliteal endovascular procedures performed in diabetic patients with critical limb ischemia and tissue loss from the perspective of an angiosome-oriented revascularization strategy. Int J Vasc Med 2014; 2014: 270539.
17. Virkkunen J, Heikkinen M, Lepantalo M, Metsanoja R, Salenius JP,. Diabetes as an independent risk factor for early postoperative complications in critical limb ischemia. J Vasc Surg 2004; 40: 761-767.
18. Biancari F, Salenius JP, Heikkinen M, Luther M, Ylonen K, Lepantalo M,. Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: A Finnvasc registry study. World J Surg 2007; 31: 217-225; discussion 226-227.
19. Awad S, Karkos CD, Serrachino-Inglott F, Cooper NJ, Butterfield JS, Ashleigh R, Nasim A,. The impact of diabetes on current revascularisation practice and clinical outcome in patients with critical lower limb ischaemia. Eur J Vasc Endovasc Surg 2006; 32: 51-59.
20. Kolluru GK, Bir SC, Kevil CG,. Endothelial dysfunction and diabetes: Effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med 2012; 2012: 918267.
21. Wallaert JB, Nolan BW, Adams J, Stanley AC, Eldrup-Jorgensen J, Cronenwett JL, Goodney PP,. The impact of diabetes on postoperative outcomes following lower-extremity bypass surgery. J Vasc Surg 2012; 56: 1317-1323.
22. Brosi P, Baumgartner I, Silvestro A, Do DD, Mahler F, Triller J, Diehm N,. Below-the-knee angioplasty in patients with end-stage renal disease. J Endovasc Ther 2005; 12: 704-713.
23. O'Hare AM, Sidawy AN, Feinglass J, Merine KM, Daley J, Khuri S, Henderson WG, Johansen KL,. Influence of renal insufficiency on limb loss and mortality after initial lower extremity surgical revascularization. J Vasc Surg 2004; 39: 709-716.
24. Kumada Y, Aoyama T, Ishii H, Tanaka M, Kawamura Y, Takahashi H, Toriyama T, Aoyama T, Yuzawa Y, Maruyama S, and others. Long-term outcome of percutaneous transluminal angioplasty in chronic haemodialysis patients with peripheral arterial disease. Nephrol Dial Transplant 2008; 23: 3996-4001.
25. Nakano M, Hirano K, Iida O, Soga Y, Kawasaki D, Suzuki K, Miyashita Y,. Prognosis of critical limb ischemia in hemodialysis patients after isolated infrapopliteal balloon angioplasty: Results from the Japan below-the-knee artery treatment (J-BEAT) registry. J Endovasc Ther 2013; 20: 113-124.
26. Guntani A, Yamaoka T, Okadome J, Kawakubo E, Kyuragi R, Homma K, Iwasa K, Matsumoto T, Okazaki J, Maehara Y,. Evaluation of the paramalleolar bypass for critical limb ischemia patients on hemodialysis with diabetes mellitus and chronic renal failure. Ann Vasc Dis 2013; 6: 596-600.
27. Svensson H, Apelqvist J, Larsson J, Lindholm E, Eneroth M,. Minor amputation in patients with diabetes mellitus and severe foot ulcers achieves good outcomes. J Wound Care 2011; 20: 261-262, 264, 266 passim.
28. Iida O, Nakamura M, Yamauchi Y, Kawasaki D, Yokoi Y, Yokoi H, Soga Y, Zen K, Hirano K, Suematsu N, et al. Endovascular treatment for infrainguinal vessels in patients with critical limb ischemia: OLIVE registry, a prospective, multicenter study in Japan with 12-month follow-up. Circ Cardiovasc Interv 2013; 6: 68-76.
29. Treiman GS, Oderich GS, Ashrafi A, Schneider PA,. Management of ischemic heel ulceration and gangrene: An evaluation of factors associated with successful healing. J Vasc Surg 2000; 31: 1110-1118.
30. Fernandez N, McEnaney R, Marone LK, Rhee RY, Leers S, Makaroun M, Chaer RA,. Multilevel versus isolated endovascular tibial interventions for critical limb ischemia. J Vasc Surg 2011; 54: 722-729.
31. Soderstrom M, Arvela E, Alback A, Aho PS, Lepantalo M,. Healing of ischaemic tissue lesions after infrainguinal bypass surgery for critical leg ischaemia. Eur J Vasc Endovasc Surg 2008; 36: 90-95.
32. Werner M, Schmidt A, Freyer M, Bausback Y, Braunlich S, Friedenberger J, Schuster J, Botsios S, Scheinert D, Ulrich M,. Sirolimus-eluting stents for the treatment of infrapopliteal arteries in chronic limb ischemia: Long-term clinical and angiographic follow-up. J Endovasc Ther 2012; 19: 12-19.
33. Liistro F, Porto I, Angioli P, Grotti S, Ricci L, Ducci K, Falsini G, Ventoruzzo G, Turini F, Bellandi G, et al. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): A randomized trial in diabetic patients with critical limb ischemia. Circulation 2013; 128: 615-621.
34. Roberts D, Niazi K, Miller W, Krishnan P, Gammon R, Schreiber T, Shammas NW, Clair D, on behalf of the DCI. Effective endovascular treatment of calcified femoropopliteal disease with directional atherectomy and distal embolic protection: Final results of the DEFINITIVE Ca trial. Catheter Cardiovasc Interv 2014.
35. Stoner MC, deFreitas DJ, Phade SV, Parker FM, Bogey WM, Powell S,. Mid-term results with laser atherectomy in the treatment of infrainguinal occlusive disease. J Vasc Surg 2007; 46: 289-295.
36. Losordo DW, Kibbe MR, Mendelsohn F, Marston W, Driver VR, Sharafuddin M, Teodorescu V, Wiechmann BN, Thompson C, Kraiss L, et al. A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia. Circ Cardiovasc Interv 2012; 5: 821-830.
37. Hart CA, Tsui J, Khanna A, Abraham DJ, Baker DM,. Stem cells of the lower limb: Their role and potential in management of critical limb ischemia. Exp Biol Med (Maywood) 2013; 238: 1118-1126.